Screening canonical molecular pathways for putative targets of FOXP2 we observe that from angiogenesis/neovasculogenesis to glucose metabolism and apoptosis, different cancer-promoting physiological processes might be impacted by FOXP2 dysregulation. Here, FOXP2 is linked to cancer.